
AusBiotech Backs Shadow Ministry for Life Sciences
AusBiotech welcomes the announcement of Australia’s federal Shadow Ministry and looks forward to the continued opportunity for engagement with the newly appointed team, as part of its ongoing commitment to supporting a strong, innovative life sciences sector.
As Australia’s peak life sciences body, AusBiotech recognises the important role of the Shadow Ministry in contributing to national policy discussions and shaping long-term thinking on key industries, including life sciences.
AusBiotech extends its congratulations to the Leader of the Opposition, the Hon Sussan Ley MP, and to the newly announced Shadow Ministers, including:
The announcement of the new Shadow Ministry provides an opportunity to continue bipartisan conversations that support Australia’s growing life sciences ecosystem — spanning biotechnology, pharmaceuticals, medical technology, and related industries.
Comments from AusBiotech CEO Rebekah Cassidy:
“With more than 2,900 life sciences organisations across the country, employing one in every 60 Australians, the life sciences sector is a significant contributor to both national health and economic outcomes.
“We believe that strong collaboration across all sides of politics is key to supporting a sustainable, competitive life sciences sector. We welcome the opportunity to continue sharing insights from across the sector with the Shadow Ministry as part of our policy work.”
AusBiotech’s key areas for engagement include:
“Australia has world-class strengths in research, clinical trials, and advanced manufacturing,” said Ms Cassidy. “With the right policy settings and partnerships, there is a significant opportunity to expand the sector’s contribution both locally and globally.”
AusBiotech looks forward to continued engagement with the Shadow Ministry, government, and broader stakeholders to support the long-term growth of Australia’s life sciences industry.
https://www.ausbiotech.org/news/ausbiotech-welcomes-announcement-of-federal-shadow-ministry-and-encourages-bipartisan-support-for-australias-life-sciences-sector